Clinical evaluation of cervical composite resin restorations placed without retention.

T. Ziemiecki,J. Dennison,G. T. Charbeneau

Operative Dentistry

Abstract:

What problem does this paper attempt to address?

Stimuli-Sensitive Nanotherapies for the Treatment of Osteoarthritis

Zhaoyi Wang,Shuqin Wang,Kai Wang,Xinyu Wu,Chenxi Tu,Changyou Gao

DOI: https://doi.org/10.1002/mabi.202100280

2021-01-01

Macromolecular Bioscience

Abstract:Osteoarthritis (OA) is a common chronic inflammatory disease in the joints. It is one of the leading causes of disability with increasing morbidity, which has become one of the serious clinical issues. Current treatments would only provide temporary relief due to the lack of early diagnosis and effective therapy, and thus the replacement of joints may be needed when the OA deteriorates. Although the intra-articular injection and oral administration of drugs are helpful for OA treatment, they are suffering from systemic toxicity, short retention time in joint, and insufficient bioavailability. Nanomedicine is potential to improve the drug delivery efficiency and targeting ability. In this focused progress review, the particle-based drug loading systems that can achieve targeted and triggered release are summarized. Stimuli-responsive nanocarriers that are sensitive to endogenous microenvironmental signals such as reactive oxygen species, enzymes, pH, and temperature, as well as external stimuli such as light for OA therapy are introduced in this review. Furthermore, the nanocarriers associated with targeted therapy and imaging for OA treatment are summarized. The potential applications of nanotherapies for OA treatment are finally discussed.
Controlled Stimulus-Responsive Delivery Systems for Osteoarthritis Treatment

Qianwen Ye,Mingshuo Zhang,Shuyue Li,Wenyue Liu,Chunming Xu,Yumei Li,Renjian Xie

DOI: https://doi.org/10.3390/ijms252111799

IF: 5.6

2024-11-03

International Journal of Molecular Sciences

Abstract:Osteoarthritis (OA), a common and disabling degenerative joint disease, affects millions of people worldwide and imposes a considerable burden on patients and society due to its high prevalence and economic costs. The pathogenesis of OA is closely related to the progressive degradation of articular cartilage and the accompany inflammation; however, articular cartilage itself cannot heal and modulate the inflammation due to the lack of nerves, blood vessels, and lymph-vessels. Therefore, reliable and effective methods to treat OA remain highly desired. Local administration of drugs or bioactive materials by intra-articular injection of the delivery system represents a promising approach to treat OA, especially considering the prolonged joint retention, cartilage or chondrocytes targeting, and stimuli-responsive release to achieve precision OA therapy. This article summarizes and discusses the advances in the currently used delivery systems (nanoparticle, hydrogel, liposome, and microsphere) and then focuses on their applications in OA treatment from the perspective of endogenous stimulus (redox reactions, pH, enzymes, and temperature) and exogenous stimulus (near-infrared, magnetic, and ultrasound)-responsive release. Finally, the challenges and potential future directions for the development of nano-delivery systems are summarized.

biochemistry & molecular biology,chemistry, multidisciplinary
Stimuli-responsive Drug Delivery Systems as an Emerging Platform for Treatment of Rheumatoid Arthritis.

Xiao-Ling Xu,Kong-Jun Lu,Xiao-Qin Yao,Xiao-Ying Ying,Yong-Zhong Du

DOI: https://doi.org/10.2174/1381612825666190321104424

IF: 3.31

2019-01-01

Current Pharmaceutical Design

Abstract:Rheumatoid Arthritis (RA) is a systemic autoimmune disease accompanied by chronic inflammation. Due to the long-term infiltration in inflammatory sites, joints get steadily deteriorated, eventually resulting in functional incapacitation and disability. Despite the considerable effect, RA sufferers treated with current drug therapeutic efficacy are exposed to severe side effects. Application of Drug Delivery Systems (DDS) has improved these situations while the problem of limited drug exposure remains untackled. Stimuli-responsive DDS that are responsive to a variety of endogenous and exogenous stimuli, such as pH, redox status, and temperature, have emerged as a promising therapeutic strategy to optimize the drug release. Herein, we discussed the therapeutic regimes and serious side effects of current RA therapy, as well as focused on some of the potential stimuli-responsive DDS utilized in RA therapy. Besides, the prospective room in designing DDS for RA treatment has also been discussed.
Nanomedicine targeted anti-inflammatory therapy to deal with the 'crux' of rheumatoid arthritis

Min An,Juntao Zhang,Xiaojie Zhang,Yumeng Zhao,Yanhua Liu

DOI: https://doi.org/10.1080/1061186x.2024.2315475

2024-02-17

Journal of Drug Targeting

Abstract:Rheumatoid arthritis is a chronic and complex autoimmune disease that is marked by an inflammatory response, synovial hyperplasia, vascularisation, fascial formation, cartilage and bone destruction, which can lead to joint deformity and even loss of function, ultimately affecting a person's health and quality of life. Although the pathogenesis of RA is unclear, growing evidence suggests that inflammation-associated cells infiltrate joints, causing tissue damage, inflammation and pain. This disruption in the balance between host tolerance and immune homeostasis the progression of RA. Existing drug therapy and surgical treatments for RA are unable to completely cure the disease or reverse its accelerated progression. Therefore, the design and development of an appropriate and effective drug delivery system will substantially improve the therapeutic effect. In this review, by describing the inflammatory microenvironment of rheumatoid arthritis and the associated inflammatory cells, the progress of targeting strategies and applications of nanotechnology in the disease is summarised, which will be helpful in providing new ideas for the subsequent treatment of rheumatoid arthritis.

pharmacology & pharmacy
Recent advances in nano-targeting drug delivery systems for rheumatoid arthritis treatment

Hanmei Li,Rui Gou,Jiaying Liao,Yao Wang,Rui Qu,Qi Tang,Jingyao Gan,Liang Zou,Sanjun Shi

DOI: https://doi.org/10.15212/amm-2022-0039

2023-01-18

Acta Materia Medica

Abstract:Rheumatoid arthritis is a systemic inflammatory disease that can lead to articular cartilage destruction and periarticular bone erosion, thus ultimately compromising joint integrity and function. Anti-inflammatory drugs and biological agents are commonly used to treat rheumatoid arthritis, but they cannot selectively target inflamed joints, because of their systemic mechanisms, short half-lives and low bioavailability. Consequently, these agents must be used at high doses and delivered frequently, thereby increasing costs and the risk of adverse effects. Drug delivery systems, such as nanoparticles, liposomes and micelles, can significantly prolong drug half-life in the body and enable targeted delivery into the joints. In this review, we comprehensively describe the pathogenesis and clinical diagnosis of rheumatoid arthritis, and summarize recent advances in targeted therapeutic strategies, particularly nano-targeting systems for rheumatoid arthritis.
Aerosol-cloud-climate interactions in the climate model CAM-Oslo

A. Kirkevåg,T. Iversen,Ø. Seland,J. Debernard,T. Storelvmo,J. Kristjánsson

DOI: https://doi.org/10.1111/j.1600-0870.2007.00313.x

2008-01-01

Abstract:A new aerosol module is integrated on-line in the atmospheric GCM CAM-Oslo coupled to a slab ocean for equilibrium climate response studies. The response to an anthropogenic change in aerosols since pre-industrial times is compared with that of a future 63% increased CO2 level. The aerosol module calculates concentrations of sea-salt, mineral dust, sulphate, black carbon (BC) and particulate organic matter (POM). Look-up tables, constructed from first principles, are used to obtain optical parameters and cloud droplet numbers (CDNC) for any given aerosol composition. Anthropogenic aerosols thus produce a global near-surface cooling of 1.94Kand a 5.5% precipitation decrease, including amplifications by positive cloud feedbacks. In comparison, the CO2 increase gives a warming of 1.98 K and a 3.8% precipitation increase, causing slightly reduced sulphate, BC, POM and sea-salt burdens. A minor increase in mineral dust is ascribed to reduced subtropical precipitation downwind of Sahara over the Atlantic Ocean. The modelled indirect effects are probably overestimated, mainly due to neglected natural aerosol components and the diagnostic scheme for CDNC. Adding 15cm−3 to CDNC everywhere reduces the indirect forcing from −2.34 to −1.36 Wm−2, whilst solving a prognostic equation for CDNC reduces it from −2.34 to −1.44 Wm−2.
Stimulus-Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy

Haoyu Yu,Rongyao Gao,Yuxin Liu,Limin Fu,Jing Zhou,Luoyuan Li

DOI: https://doi.org/10.1002/advs.202306152

Abstract:Deregulated inflammations induced by various factors are one of the most common diseases in people's daily life, while severe inflammation can even lead to death. Thus, the efficient treatment of inflammation has always been the hot topic in the research of medicine. In the past decades, as a potential biomaterial, stimuli-responsive hydrogels have been a focus of attention for the inflammation treatment due to their excellent biocompatibility and design flexibility. Recently, thanks to the rapid development of nanotechnology and material science, more and more efforts have been made to develop safer, more personal and more effective hydrogels for the therapy of some frequent but tough inflammations such as sepsis, rheumatoid arthritis, osteoarthritis, periodontitis, and ulcerative colitis. Herein, from recent studies and articles, the conventional and emerging hydrogels in the delivery of anti-inflammatory drugs and the therapy for various inflammations are summarized. And their prospects of clinical translation and future development are also discussed in further detail.
Towards an arthritis flare-responsive drug delivery system

Nitin Joshi,Jing Yan,Seth Levy,Sachin Bhagchandani,Kai V Slaughter,Nicholas E Sherman,Julian Amirault,Yufeng Wang,Logan Riegel,Xueyin He,Tan Shi Rui,Michael Valic,Praveen K Vemula,Oscar R Miranda,Oren Levy,Ellen M Gravallese,Antonios O Aliprantis,Joerg Ermann,Jeffrey M Karp

DOI: https://doi.org/10.1038/s41467-018-03691-1

2018-04-03

Abstract:Local delivery of therapeutics for the treatment of inflammatory arthritis (IA) is limited by short intra-articular half-lives. Since IA severity often fluctuates over time, a local drug delivery method that titrates drug release to arthritis activity would represent an attractive paradigm in IA therapy. Here we report the development of a hydrogel platform that exhibits disassembly and drug release controlled by the concentration of enzymes expressed during arthritis flares. In vitro, hydrogel loaded with triamcinolone acetonide (TA) releases drug on-demand upon exposure to enzymes or synovial fluid from patients with rheumatoid arthritis. In arthritic mice, hydrogel loaded with a fluorescent dye demonstrates flare-dependent disassembly measured as loss of fluorescence. Moreover, a single dose of TA-loaded hydrogel but not the equivalent dose of locally injected free TA reduces arthritis activity in the injected paw. Together, our data suggest flare-responsive hydrogel as a promising next-generation drug delivery approach for the treatment of IA.
Trigger-responsive engineered-nanocarriers and image-guided theranostics for rheumatoid arthritis

Nadim Ahamad,Ameya Prabhakar,Sourabh Mehta,Ekta Singh,Eshant Bhatia,Shivam Sharma,Rinti Banerjee

DOI: https://doi.org/10.1039/d0nr01648a

IF: 6.7

2020-06-28

Nanoscale

Abstract:Rheumatoid Arthritis (RA), one of the leading causes of disability due to progressive autoimmune destruction of synovial joints, affects ∼1% of the global population. Standard therapy helps in reducing inflammation and delaying the progression of RA but is limited by non-responsiveness on long-term use and several side-effects. The conventional nanocarriers (CNCs), to some extent, minimize toxicity associated with free drug administration while improving the therapeutic efficacy. However, the uncontrolled release of the encapsulated drug even at off-targeted organs limits the application of CNCs. To overcome these challenges, trigger-responsive engineered nanocarriers (ENCs) have been recently explored for RA treatment. Unlike CNCs, ENCs enable precise control over on-demand drug release due to endogenous triggers in arthritic paws like pH, enzyme level, oxidative stress, or exogenously applied triggers like near-infrared light, magnetic field, ultrasonic waves, etc. As the trigger is selectively applied to the inflamed joint, it potentially reduces toxicity at off-target locations. Moreover, ENCs have been strategically coupled with imaging probe(s) for simultaneous monitoring of ENCs inside the body and facilitate an 'image-guided-co-trigger' for site-specific action in arthritic paws. In this review, the progress made in recently emerging 'trigger-responsive' and 'image-guided theranostics' ENCs for RA treatment has been explored with emphasis on the design strategies, mechanism, current status, challenges, and translational perspectives.
Advances in local drug delivery technologies for improved rheumatoid arthritis therapy

Xiaoran An,Jiapei Yang,Xiaolin Cui,Jiaxuan Zhao,Chenwei Jiang,Minglu Tang,Yabing Dong,Longfei Lin,Hui Li,Feihu Wang

DOI: https://doi.org/10.1016/j.addr.2024.115325

Abstract:Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease characterized by an inflammatory microenvironment and cartilage erosion within the joint cavity. Currently, antirheumatic agents yield significant outcomes in RA treatment. However, their systemic administration is limited by inadequate drug retention in lesion areas and non-specific tissue distribution, reducing efficacy and increasing risks such as infection due to systemic immunosuppression. Development in local drug delivery technologies, such as nanostructure-based and scaffold-assisted delivery platforms, facilitate enhanced drug accumulation at the target site, controlled drug release, extended duration of the drug action, reduced both dosage and administration frequency, and ultimately improve therapeutic outcomes with minimized damage to healthy tissues. In this review, we introduced pathogenesis and clinically used therapeutic agents for RA, comprehensively summarized locally administered nanostructure-based and scaffold-assisted drug delivery systems, aiming at improving the therapeutic efficiency of RA by alleviating the inflammatory response, preventing bone erosion and promoting cartilage regeneration. In addition, the challenges and future prospects of local delivery for clinical translation in RA are discussed.
The Therapeutic Potential of Targeted Nanoparticulate Systems to Treat Rheumatoid Arthritis

Wenqing Liang,Yijun Yu,Zunyong Liu,Wenyi Ming,Hongming Lin,Hengguo Long,Jiayi Zhao

DOI: https://doi.org/10.1155/2022/8900658

IF: 3.791

2022-10-13

Journal of Nanomaterials

Abstract:Rheumatoid arthritis (RA) is a widespread autoimmune inflammatory disease. It implicates damage to bones, cartilage, and joints with uncertain pathogenesis. It is coupled with an elevated risk of cardiovascular complications and human disability. The conventional dosage forms for RA treatment pose numerous problems including poor efficacy, large dosages, frequent administration, limited responsiveness, greater expenses, and severe side effects. The nanoparticulate systems are emerging as a new thought for the diagnosis and treatment of RA. Anti-inflammatory drug-loaded nanoparticulate systems aid in the active and passive targeting of the inflamed region. Improved bioavailability and targetability are achieved by using these systems. In this review, the pathophysiology of RA and its conventional treatment has been discussed. The role of various nanoparticulate systems for passive and active targeting of RA has been reviewed. The authors have summarized the current practices in the typical and novel nanosystems to improve the quality of life in RA patients.

materials science, multidisciplinary,nanoscience & nanotechnology
Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases

Zhengyu Deng,Shiyong Liu

DOI: https://doi.org/10.1007/s13346-021-00977-8

Abstract:Inflammation is the biological response of immune system to protect living organisms from injurious factors. However, excessive and uncontrolled inflammation is implicated in a variety of devastating chronic diseases including atherosclerosis, inflammatory bowel disease (IBD), and rheumatoid arthritis (RA). Improved understanding of inflammatory response has unveiled a rich assortment of anti-inflammatory therapeutics for the treatment and management of relevant chronic diseases. Notwithstanding these successes, clinical outcomes are variable among patients and serious adverse effects are often observed. Moreover, there exist some limitations for clinical anti-inflammatory therapeutics such as aqueous insolubility, low bioavailability, off-target effects, and poor accessibility to subcellular compartments. To address these challenges, the rational design of inflammation-specific drug delivery systems (DDSs) holds significant promise. Moreover, as compared to normal tissues, inflamed tissue-associated pathological milieu (e.g., oxidative stress, acidic pH, and overexpressed enzymes) provides vital biochemical stimuli for triggered delivery of anti-inflammatory agents in a spatiotemporally controlled manner. In this review, we summarize recent advances in the development of anti-inflammatory DDSs with built-in pathological inflammation-specific responsiveness for the treatment of chronic inflammatory diseases.
[Bone metabolism during pregnancy and breast feeding. Osteoporosis in pregnancy].

M. Audran

Abstract:
Nanoparticle-Based Drug Delivery System—A Target Strategy for Osteoarthritis Treatment

Keda Liu,Dianjian Zhang,Wei Wang

DOI: https://doi.org/10.1155/2021/4064983

IF: 3.791

2021-10-20

Journal of Nanomaterials

Abstract:Osteoarthritis (OA) is a bone and joint disease with pathological characteristics such as articular cartilage degeneration injury and synovial and subchondral bone reactive hyperplasia. Once cartilage is damaged, it is difficult to repair it by itself. Current clinical practice is mainly limited to symptomatic treatment, not changing the degenerative process of osteoarthritis. The important goal of nanomedicine is targeted delivery. Nanoparticles (NPs) can provide many unique potential functions for the targeted treatment of arthritis. This review summarizes the research progress of nanomaterials as a drug delivery system in the treatment of osteoarthritis from three aspects: (1) the etiology of OA and the current research status of applying nanoparticles to treat OA, (2) the construction of osteoarthritis models, and (3) the classification of nanoparticle-based drug delivery systems.

materials science, multidisciplinary,nanoscience & nanotechnology
Advances in stimulus-responsive nanomedicine for treatment and diagnosis of atherosclerosis

Jingying Mao,Chengxi Wu,Lixin Zheng,Yaoyao Li,Ronghao Yang,Ping Yuan,Jun Jiang,Chunhong Li,Xiangyu Zhou

DOI: https://doi.org/10.1016/j.colsurfb.2024.114298

Abstract:Atherosclerosis (AS), an inflammatory cardiovascular disease driven by lipid deposition, presents global prevalence with high mortality. Effective anti-inflammatory or lipid removal is a promising strategy. However, current conventional drug delivery methods may face challenges in targeting disease sites and are deficient in the treatment of AS because of the nonspecific tissue distribution and uncontrollable release of the drug. In contrast, stimulus-responsive nanodrug delivery systems (NDDSs) can respond to stimulation and achieve controlled drug release rates at specific disease sites owing to the abnormal pathological microenvironment in plaques with low pH, excessive reactive oxygen species (ROS) and enzymes, and high shear stress. As a consequence, the efficacy of treatment is improved, and adverse reactions are reduced. On the other hand, NDDSs can combine exogenous stimulus responses (photothermal, ultrasound, etc.) to precisely control their function in time and space. This review for the first time focuses on the application of stimulus-responsive NDDSs in the treatment and diagnosis of AS in the last five years. In addition, its pivotal challenges and prospects are emphasized, aiming to facilitate its application for AS.
Advancements in pH-Responsive nanoparticles for osteoarthritis treatment: Opportunities and challenges

Shuai Liao,Shicheng Jia,Yaohang Yue,Hui Zeng,Jianjin Lin,Peng Liu

DOI: https://doi.org/10.3389/fbioe.2024.1426794

IF: 5.7

2024-07-01

Frontiers in Bioengineering and Biotechnology

Abstract:Osteoarthritis (OA) is a degenerative disease linked to aging and obesity. The global aging population has led to an increasing number of OA patients, imposing a significant economic burden on society. Traditional drugs treatment methods often fail to achieve satisfactory outcomes. With the rapid advancement of nanomaterial delivery systems, numerous studies have focused on utilizing nanomaterials as carriers to achieve efficient OA treatment by effectively loading and delivering bioactive ingredients (e.g., drugs, nucleic acids) tailored to the unique pathological conditions, such as the weakly acidic microenvironment of synovial fluid in OA patients. This review highlights the latest advancements in the use of pH-responsive nanoparticles for OA treatment, emphasizing the principle of targeted drug delivery leveraging the acidic microenvironment of inflamed joints. It further discusses the composition, synthesis, response mechanism, target selection, application, and recent research findings of nanoparticles, while also addressing the challenges and future directions in this promising field.

multidisciplinary sciences
Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment

Huailan Wang,Yunxiang Zhou,Qunan Sun,Chenghao Zhou,Shiyao Hu,Cameron Lenahan,Weilin Xu,Yongchuan Deng,Gonghui Li,Sifeng Tao

DOI: https://doi.org/10.3389/fbioe.2021.630352

IF: 5.7

2021-02-17

Frontiers in Bioengineering and Biotechnology

Abstract:Nanobiotechnology plays an important role in drug delivery, and various kinds of nanoparticles have demonstrated new properties, which may provide opportunities in clinical treatment. Nanoparticle-mediated drug delivery systems have been used in anti-inflammatory therapies. Diseases, such as inflammatory bowel disease, rheumatoid arthritis, and osteoarthritis have been widely impacted by the pathogenesis of inflammation. Efficient delivery of anti-inflammatory drugs can reduce medical dosage and improve therapeutic effect. In this review, we discuss nanoparticles with potential anti-inflammatory activity, and we present a future perspective regarding the application of nanomedicine in inflammatory diseases.

multidisciplinary sciences
Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management

Juan Wen,Huimin Li,Huan Dai,Shu Hua,Xing Long,Huang Li,Saso Ivanovski,Chun Xu

DOI: https://doi.org/10.1016/j.mtbio.2023.100597

2023-01-01

Abstract:Osteoarthritis (OA) and rheumatoid arthritis (RA) are chronic and progressive inflammatory joint diseases that affect a large population worldwide. Intra-articular administration of various therapeutics is applied to alleviate pain, prevent further progression, and promote cartilage regeneration and bone remodeling in both OA and RA. However, the effectiveness of intra-articular injection with traditional drugs is uncertain and controversial due to issues such as rapid drug clearance and the barrier afforded by the dense structure of cartilage. Nanoparticles can improve the efficacy of intra-articular injection by facilitating controlled drug release, prolonged retention time, and enhanced penetration into joint tissue. This review systematically summarizes nanoparticle-based therapies for OA and RA management. Firstly, we explore the interaction between nanoparticles and joints, including articular fluids and cells. This is followed by a comprehensive analysis of current nanoparticles designed for OA/ RA, divided into two categories based on therapeutic mechanisms: direct therapeutic nanoparticles and nanoparticles-based drug delivery systems. We highlight nanoparticle design for tissue/cell targeting and controlled drug release before discussing challenges of nanoparticle-based therapies for efficient OA and RA treatment and their future clinical translation. We anticipate that rationally designed local injection of nano -particles will be more effective, convenient, and safer than the current therapeutic approach.
[Classification and Application of Ultrasound-Responsive Nanomaterials in Anti-Inflammatory Therapy]

Lixin Xie,Zhefei DU,Qiuxia Peng,Kun Zhang,Chao Fang

DOI: https://doi.org/10.12182/20240760104

2024-07-20

Abstract:Ultrasound, a high-frequency mechanical wave with excellent tissue penetration, has been widely applied in medical diagnostic imaging. Furthermore, it has been reported that ultrasound has broad prospects for extensive applications in the field of disease treatment in recent years due to its non-invasiveness and high efficiency. Ultrasound-responsive nanomaterials have the unique advantages of a small size and a high reactivity. Such materials have the capability for precision control of drug release under ultrasound stimulation, which provides a new approach to enhancing the efficiency of drug therapy. Therefore, these materials have attracted the attention of a wide range of scholars. Inflammation is a defensive response produced by organisms to deal with injuries. However, excessive inflammatory response may lead to various tissue damages in organisms and even endanger patients' lives. Many studies have demonstrated that limiting the inflammatory response using ultrasound-responsive nanomaterials is a viable way of treating diseases. Currently, there are still challenges in the application of ultrasound-responsive nanomaterials in anti-inflammatory therapy. The design and synthesis process of nanomaterials is complicated, and further verification of the biocompatibility and safety of these materials is needed. Therefore, in this review, we summarized and classified common ultrasound-responsive nanomaterials in the field of anti-inflammation and systematically introduced the properties of different nanomaterials. In addition, the anti-inflammatory applications of ultrasound-responsive nanomaterials in various diseases, such as bone diseases, skin and muscle diseases, autoimmune diseases, and respiratory diseases, are also described in detail. It is expected that this review will provide insights for further research and clinical applications in the realms of precision treatment, targeted drug delivery, and clinical trial validation of ultrasound-responsive nanomaterials used in anti-inflammatory therapies.
Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis

Yanyan Zhang,Zhaoju Gao,Shushu Chao,Wenjuan Lu,Pingping Zhang

DOI: https://doi.org/10.1080/10717544.2022.2089295

IF: 6.819

2022-06-28

Drug Delivery

Abstract:Rheumatoid arthritis is a chronic autoimmune disease, with the features of recurrent chronic inflammation of synovial tissue, destruction of cartilage, and bone erosion, which further affects joints tissue, organs, and systems, and eventually leads to irreversible joint deformities and body dysfunction. Therapeutic drugs for rheumatoid arthritis mainly reduce inflammation through regulating inflammatory factors. Transdermal administration is gradually being applied to the treatment of rheumatoid arthritis, which can allow the drug to overcome the skin stratum corneum barrier, reduce gastrointestinal side effects, and avoid the first-pass effect, thus improving bioavailability and relieving inflammation. This paper reviewed the latest research progress of transdermal drug delivery in the treatment of rheumatoid arthritis, and discussed in detail the dosage forms such as gel (microemulsion gel, nanoemulsion gel, nanomicelle gel, sanaplastic nano-vesiclegel, ethosomal gel, transfersomal gel, nanoparticles gel), patch, drug microneedles, nanostructured lipid carrier, transfersomes, lyotropic liquid crystal, and drug loaded electrospinning nanofibers, which provide inspiration for the rich dosage forms of transdermal drug delivery systems for rheumatoid arthritis.

pharmacology & pharmacy

Clinical evaluation of cervical composite resin restorations placed without retention.

Stimuli-Sensitive Nanotherapies for the Treatment of Osteoarthritis

Controlled Stimulus-Responsive Delivery Systems for Osteoarthritis Treatment

Stimuli-responsive Drug Delivery Systems as an Emerging Platform for Treatment of Rheumatoid Arthritis.

Nanomedicine targeted anti-inflammatory therapy to deal with the 'crux' of rheumatoid arthritis

Recent advances in nano-targeting drug delivery systems for rheumatoid arthritis treatment

Aerosol-cloud-climate interactions in the climate model CAM-Oslo

Stimulus-Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy

Towards an arthritis flare-responsive drug delivery system

Trigger-responsive engineered-nanocarriers and image-guided theranostics for rheumatoid arthritis

Advances in local drug delivery technologies for improved rheumatoid arthritis therapy

The Therapeutic Potential of Targeted Nanoparticulate Systems to Treat Rheumatoid Arthritis

Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases

[Bone metabolism during pregnancy and breast feeding. Osteoporosis in pregnancy].

Nanoparticle-Based Drug Delivery System—A Target Strategy for Osteoarthritis Treatment

Advances in stimulus-responsive nanomedicine for treatment and diagnosis of atherosclerosis

Advancements in pH-Responsive nanoparticles for osteoarthritis treatment: Opportunities and challenges

Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment

Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management

[Classification and Application of Ultrasound-Responsive Nanomaterials in Anti-Inflammatory Therapy]

Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis